cannabidiol/neoplasms

TECHNICAL FIELD This invention relates to methods and compositions for treating cancer. More particularly, the invention provides cannabidiol derivatives and compositions thereof. BACKGROUND The hemp plant Cannabis sativa, commonly referred to as marijuana, has been used to alleviate symptoms of

FIELD Described herein are microneedle drug delivery systems comprising: a pharmaceutical composition comprising pharmaceutically active agents (e.g., cannabinoids, such as cannabidiol or prodrugs of cannabidiol) and microneedle arrays suitable for local and systemic delivery to a mammal, including

RELATED APPLICATION This application is a national stage filing under 35 U.S.C. .sctn. 371 of International Application No. PCT/GB2015/051876, filed Jun. 26, 2015, which was published under PCT Article 21(2) in English, the entire contents of which are hereby incorporated by reference. The present

TECHNICAL FIELD OF THE INVENTION The present invention pertains to a treatment for diseases associated with immune dysfunction, particularly HIV disease and neoplastic disorders. BACKGROUND OF THE INVENTION The retroviral Human Immunodeficiency Viruses 1 and 2 (HIV) are the most common causative

RELATED APPLICATIONS This application is a national stage filing under 35 U.S.C. .sctn.371 of international application PCT/GB2009/050621, filed Jun. 4, 2009, which was published under PCT Article 21(2) in English. The present invention relates to the use of a combination of cannabinoids in the

FIELD OF THE INVENTION The present invention relates to treatment of cancer related pain and constipation. Preferably the subject in need is administered a combination of the cannabinoids cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC). More preferably the cannabinoids are in a predefined

FIELD OF THE INVENTION The present invention relates to treatment of cancer related pain and constipation. Preferably the subject in need is administered a combination of the cannabinoids cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC). More preferably the cannabinoids are in a predefined

RELATED APPLICATION This application is a national stage filing under 35 U.S.C. .sctn. 371 of international application PCT/GB2014/051889, filed Jun. 19, 2014, which was published under PCT Article 21(2) in English, the disclosure of which is incorporated by reference herein in its entirety. The